Attorney General Andy Beshear announced Wednesday, December 20, 2017 that his office secured $152,000 for the state’s General Fund from a settlement with a Connecticut-based pharmaceutical company for improperly promoting its drugs to Kentuckians. The multi-million dollar nationwide, multi-state settlement resolves allegations Boehringer Ingelheim Pharmaceuticals Inc. misrepresented drugs as effective in treating heart conditions and COPD without evidence to substantiate the claims. The settlement requires Boehringer Ingelheim ensure that its marketing and promotional practices do not unlawfully promote the prescription drug products Aggrenox, Micardis, Combivent, and Atrovent.
Kentucky General Fund Adds $152,000 from Pharmaceutical Settlement
Be the first to comment